Compass Therapeutics, Inc. (CMPX) Net Income by Year
Compass Therapeutics, Inc. reported a net loss of $66.5M in fiscal year 2025. This represents a decrease of 34.7% from the prior fiscal year. The table below carries 8 fiscal years, from 2019 to 2025, and the quarters Compass Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CMPX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
CMPX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Compass Therapeutics, Inc. financials
Frequently Asked Questions
What was Compass Therapeutics, Inc.'s net income in fiscal year 2025?
Compass Therapeutics, Inc. reported a net loss of $66.5M in fiscal year 2025.
How fast is Compass Therapeutics, Inc.'s net income growing?
Compass Therapeutics, Inc. (CMPX) net income fell by 34.7% year over year, from -$49.4M to -$66.5M in fiscal year 2025.
What was Compass Therapeutics, Inc.'s net income in the most recent quarter?
Compass Therapeutics, Inc. (CMPX) reported -$25.2M in net income in Q2 2026. This represents a decrease of 26.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Compass Therapeutics, Inc. (CMPX) reported on that line in every period on record.